These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 17354307)

  • 1. Bivalirudin in acute coronary syndromes.
    Bonvini RF; Verin V; Righini M
    N Engl J Med; 2007 Mar; 356(10):1070; author reply 1070-1. PubMed ID: 17354307
    [No Abstract]   [Full Text] [Related]  

  • 2. Bivalirudin in acute coronary syndromes.
    Sanmartin M
    N Engl J Med; 2007 Mar; 356(10):1069-70; author reply 1070-1. PubMed ID: 17347463
    [No Abstract]   [Full Text] [Related]  

  • 3. Accounting for ACUITY.
    Bittl JA
    N Engl J Med; 2006 Nov; 355(21):2249-50. PubMed ID: 17124024
    [No Abstract]   [Full Text] [Related]  

  • 4. Bivalirudin for patients with acute coronary syndromes.
    Stone GW; McLaurin BT; Cox DA; Bertrand ME; Lincoff AM; Moses JW; White HD; Pocock SJ; Ware JH; Feit F; Colombo A; Aylward PE; Cequier AR; Darius H; Desmet W; Ebrahimi R; Hamon M; Rasmussen LH; Rupprecht HJ; Hoekstra J; Mehran R; Ohman EM;
    N Engl J Med; 2006 Nov; 355(21):2203-16. PubMed ID: 17124018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial.
    Rajagopal V; Lincoff AM; Cohen DJ; Gurm HS; Hu T; Desmet WJ; Kleiman NS; Bittl JA; Feit F; Topol EJ
    Am Heart J; 2006 Jul; 152(1):149-54. PubMed ID: 16824845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bivalirudin anticoagulation for a patient with hypercoagulable immune syndromes undergoing mitral valve surgery.
    Cain RL; Spiess BD; Nelson M; Deanda A; McCarthy HL; Green JA
    Ann Thorac Surg; 2006 Jun; 81(6):2308-10. PubMed ID: 16731183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bivalirudin.
    Warkentin TE; Greinacher A; Koster A
    Thromb Haemost; 2008 May; 99(5):830-9. PubMed ID: 18449412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of protamine allergy with bivalirudin during coronary artery revascularization.
    Koster A; Rosendahl U; von Hodenberg E; Ennker J
    Ann Thorac Surg; 2010 Jul; 90(1):276-7. PubMed ID: 20609794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale.
    Stone GW; Bertrand M; Colombo A; Dangas G; Farkouh ME; Feit F; Lansky AJ; Lincoff AM; Mehran R; Moses JW; Ohman M; White HD
    Am Heart J; 2004 Nov; 148(5):764-75. PubMed ID: 15523305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biventricular thrombus resolution and antibody formation during lepirudin therapy. Comment on the article from DMW 28-29/2003].
    Nowak G
    Dtsch Med Wochenschr; 2003 Nov; 128(45):2389-90; author reply 2390. PubMed ID: 14606040
    [No Abstract]   [Full Text] [Related]  

  • 11. Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors.
    Lepor NE
    Rev Cardiovasc Med; 2007; 8 Suppl 3():S9-17. PubMed ID: 17917621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bivalirudin in acute coronary syndromes and percutaneous coronary intervention.
    Lee MS; Makkar RR
    Rev Cardiovasc Med; 2006; 7 Suppl 3():S27-34. PubMed ID: 17224881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Conservative management in patients with acute coronary syndrome].
    Honye J; Saito S; Kanmatsuse K
    J Cardiol; 1999 Mar; 33 Suppl 1():31-7. PubMed ID: 10342134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bivalirudin, a bivalent, thrombin specific anticoagulant as an alternative to heparin in interventional procedures as an alternative to heparin in interventional procedures.
    Chew DP
    Hamostaseologie; 2002 Aug; 22(3):60-6. PubMed ID: 12215763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of bivalirudin versus heparins in reduction of cardiac outcomes in acute coronary syndrome and percutaneous coronary interventions.
    Singh S; Molnar J; Arora R
    J Cardiovasc Pharmacol Ther; 2007 Dec; 12(4):283-91. PubMed ID: 18172222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of point-of-care ecarin clotting time versus activated clotting time with bivalirudin concentrations.
    Cho L; Kottke-Marchant K; Lincoff AM; Roffi M; Reginelli JP; Kaldus T; Moliterno DJ
    Am J Cardiol; 2003 May; 91(9):1110-3. PubMed ID: 12714157
    [No Abstract]   [Full Text] [Related]  

  • 17. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial.
    Stone GW; White HD; Ohman EM; Bertrand ME; Lincoff AM; McLaurin BT; Cox DA; Pocock SJ; Ware JH; Feit F; Colombo A; Manoukian SV; Lansky AJ; Mehran R; Moses JW;
    Lancet; 2007 Mar; 369(9565):907-19. PubMed ID: 17368152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results.
    Mahaffey KW; Lewis BE; Wildermann NM; Berkowitz SD; Oliverio RM; Turco MA; Shalev Y; Ver Lee P; Traverse JH; Rodriguez AR; Ohman EM; Harrington RA; Califf RM;
    J Invasive Cardiol; 2003 Nov; 15(11):611-6. PubMed ID: 14608128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial results with hirudin and bivalirudin for acute coronary artery syndromes.
    Bates ER
    Semin Thromb Hemost; 1997; 23(6):575-81. PubMed ID: 9469633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From the Food and Drug Administration.
    Schwetz BA
    JAMA; 2001 Feb; 285(6):724. PubMed ID: 11176890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.